171 related articles for article (PubMed ID: 38312712)
1. The molecular mechanism of "Dahuang-Shengjiang-Banxia decoction" in the treatment of diabetic kidney disease was verified based on network pharmacology and molecular docking.
Xu D; Yuan L; Che M; Liu W; Li X; Yang Y; Wang K; Nan Y
Heliyon; 2024 Jan; 10(2):e24776. PubMed ID: 38312712
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of Zicui Decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking].
Gao LD; Liu J; Huang YH; Wang BH
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3339-3347. PubMed ID: 35851128
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of
Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
[No Abstract] [Full Text] [Related]
4. [Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].
Luo YT; Lin LF; Liu YL; Shi GL; Wu YQ; Yang AH; Li H
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5753-5761. PubMed ID: 33496116
[TBL] [Abstract][Full Text] [Related]
5. The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction.
Guo JF; Zhao YT; Du QY; Ren Y; Wang Y; Wang ZX; Jin W
Biomed Res Int; 2022; 2022():2775434. PubMed ID: 35528155
[TBL] [Abstract][Full Text] [Related]
6. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Mechanisms of Pollen Typhae in the Treatment of Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking.
Zhou R; Jin D; Zhang Y; Duan L; Zhang Y; Duan Y; Kang X; Lian F
Evid Based Complement Alternat Med; 2022; 2022():5728408. PubMed ID: 35024051
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
Que DH; Chen WH; Jiang FP; Pan F; Yang K
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
[TBL] [Abstract][Full Text] [Related]
10. Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach.
Li C; Yang W; Meng Y; Feng L; Sun L; Li Z; Liu X; Li M
Metab Brain Dis; 2023 Oct; 38(7):2315-2325. PubMed ID: 37556042
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
[TBL] [Abstract][Full Text] [Related]
12. Banxia-Shengjiang drug pair inhibits gastric cancer development and progression by improving body immunity.
Yang Y; Yuan L; Liu W; Lu D; Meng F; Yang Y; Zhou Z; Ma P; Nan Y
Medicine (Baltimore); 2024 Mar; 103(10):e36303. PubMed ID: 38457601
[TBL] [Abstract][Full Text] [Related]
13. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
Wu Z; Ji X; Shan C; Song J; Zhao J
Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
15. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.
He D; Li Q; Du G; Sun J; Meng G; Chen S
Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury.
Wang Y; Chen X; Wang Y; Zhong H; Liu L; Ye Y
Medicine (Baltimore); 2023 Dec; 102(48):e36349. PubMed ID: 38050247
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
18. Exploring the pharmacological mechanisms of
Lu M; Ou J; Deng X; Chen Y; Gao Q
Heliyon; 2023 Jun; 9(6):e17550. PubMed ID: 37416640
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.
Yu Y; Zhang G; Han T; Huang H
BMC Complement Med Ther; 2020 Jun; 20(1):199. PubMed ID: 32600331
[TBL] [Abstract][Full Text] [Related]
20. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
